Labcorp reaffirms 2026-29 outlook and flags CMS PAMA rate cuts

LABCORP HOLDINGS INC.

CMS released preliminary Clinical Laboratory Fee Schedule rates for 2027-2029 under PAMA on Sept 21, 2026.
Labcorp says rates are based on non-representative data and would impose steep annual payment cuts threatening patient access.
Reaffirms 2026-29 outlook: 5-8% CAGR revenue, 75-150 bps adjusted operating margin expansion by end of 2029.
Reaffirms 8.5-11.5% CAGR adjusted EPS growth and free cash flow growth in line with adjusted earnings.
Expects to provide 2027 guidance impact in February 2027; continues to support bipartisan RESULTS Act.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.